New Support Group Empowers Vasculitis Patients Against Rare Vessel Inflammation

IMT News Desk
IMT News Desk
· 3 min read
Vasculitis Society of India launches patient support group in Ahmedabad during Rheumatology Awareness Month.

It Aims to Educate, Guide, and Give Reliable Info To Those Affected

Marking Rheumatology Awareness Month, the Vasculitis Society of India and the Rheumatology Association of Gujarat (RAG) launched the ‘Vasculitis Patient Support Group’ in Ahmedabad today. The event featured an awareness program on vasculitis, a group of rare autoimmune disorders causing blood vessel inflammation.

Originally established in Punjab, the Vasculitis Society is expanding nationwide through patient engagement and outreach to build supportive communities. The new group provides education, guidance, and reliable information to improve the quality of life for those affected.

Chief Minister Bhupendra Patel congratulated the Indian Rheumatology Association (IRA), RAG, and Vasculitis Society of India in a message. “I am especially happy that initiatives like the Vasculitis Support Group and Antardhwani have been launched to reach out to patients,” he said, commending the organizations for Rheumatology Awareness Month in April.

Challenges of Vasculitis: A Hidden Threat

Vasculitis inflames blood vessels, setting it apart from joint-focused conditions like rheumatoid arthritis. With a global prevalence of 0.02%–0.04%, these rare disorders affect organs such as the skin, kidneys, lungs, or brain. Diagnosis is tough, often mimicking tuberculosis, infections, or malignancy in India, leading to months-long delays. Limited access to tests such as ANCA testing, complement levels, or biopsies compounds the issue.

The burden is heavy: organ damage (e.g., renal failure, stroke, lung hemorrhage), chronic relapses, reduced quality of life, disability, and high costs for immunosuppressants, biologics like Rituximab, and hospitalizations.

“While each type of vasculitis is rare, collectively they affect many patients and remain underdiagnosed in India, leading to preventable complications,” said Dr. Aman Sharma, IRA President and Professor at PGI Chandigarh. He stressed boosting awareness, expanding access to specialized care, and improving nationwide management.

Dr. Sapan Pandya, IRA Vice-President and Associate Professor of Rheumatology at SVP Hospital and Smt. NHL MMC highlighted local impact: “This support group builds a community for patients and caregivers to access reliable info and guidance, empowering healthier lives through education.”

Dr. Reena Sharma, RAG President and consultant rheumatologist, added: “Vasculitis shows as rashes, fatigue, or organ issues. Early ANCA-tested diagnosis and Rituximab are vital awareness drives that lead to better outcomes.” The launch included Dr. Vishnu Sharma, Dr. Anuj Shukla, and Dr. Dhaiwat Shukla.

Upcoming Rheumatology Events

SVP Hospital faculty held bedside clinical grand rounds earlier today, teaching rheumatology skills to students. A CME for postgraduates is set for April 19 at Smt. NHL Medical College, featuring experts like Prof. Aman Sharma (PGI Chandigarh), Prof. Vikas Aggarwal (SGPGI Lucknow), and others from across India.

The Rheumatology Awareness Walkathon 2026 follows on April 26 at Ahmedabad Riverfront (7-9 am), hosted by RAG and IRA. With the theme ‘Move Free. Live Pain-Free,’ it promotes joint health, arthritis awareness, and support for rheumatic patients alongside rheumatologists and “autoimmune warriors.”

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk